These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16781316)

  • 1. Treatment of coincident seronegative arthritis and hidradentis supprativa with adalimumab.
    Scheinfeld N
    J Am Acad Dermatol; 2006 Jul; 55(1):163-4. PubMed ID: 16781316
    [No Abstract]   [Full Text] [Related]  

  • 2. The cutting edge. Severe hidradenitis suppurativa treated with adalimumab.
    Moul DK; Korman NJ
    Arch Dermatol; 2006 Sep; 142(9):1110-2. PubMed ID: 16982997
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of adalimumab in recalcitrant hidradenitis suppurativa.
    Sotiriou E; Apalla Z; Vakirlis E; Ioannides D
    Eur J Dermatol; 2009; 19(2):180-1. PubMed ID: 19153066
    [No Abstract]   [Full Text] [Related]  

  • 4. Summaries for patients. Adalimumab for the treatment of hidradenitis suppurativa.
    Ann Intern Med; 2012 Dec; 157(12):I-50. PubMed ID: 23247950
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.
    Harde V; Mrowietz U
    J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial keratitis secondary to severe hidradenitis suppurativa: a case report and literature review.
    Alzaga Fernandez AG; Demirci H; Darnley-Fisch DA; Steen DW
    Cornea; 2010 Oct; 29(10):1189-91. PubMed ID: 20628295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn's disease patient.
    Katsanos KH; Christodoulou DK; Tsianos EV
    Am J Gastroenterol; 2002 Aug; 97(8):2155-6. PubMed ID: 12190206
    [No Abstract]   [Full Text] [Related]  

  • 8. Amyloidosis secondary to hidradenitis suppurativa. Exceptional response to infliximab.
    Montes-Romero JA; Callejas-Rubio JL; Sánchez-Cano D; González-Martínez FJ; Navas-Parejo A; Ortego-Centeno N
    Eur J Intern Med; 2008 Oct; 19(6):e32-3. PubMed ID: 18848164
    [No Abstract]   [Full Text] [Related]  

  • 9. Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy.
    Arenbergerova M; Gkalpakiotis S; Arenberger P
    Int J Dermatol; 2010 Dec; 49(12):1445-9. PubMed ID: 21091684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical spectrum of the arthropathy associated with hidradenitis suppurativa and acne conglobata.
    Rosner IA; Burg CG; Wisnieski JJ; Schacter BZ; Richter DE
    J Rheumatol; 1993 Apr; 20(4):684-7. PubMed ID: 8496865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.
    Reddick CL; Singh MN; Chalmers RJ
    Dermatol Online J; 2010 Aug; 16(8):15. PubMed ID: 20804692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of hidradenitis suppurativa refractory to anti-TNFalpha therapy in a patient with Crohn's disease.
    Koilakou S; Karapiperis D; Tzathas C
    Am J Gastroenterol; 2010 Jan; 105(1):231-2. PubMed ID: 20054324
    [No Abstract]   [Full Text] [Related]  

  • 13. Rotational therapy with TNF-alpha blockers for recalcitrant hidradenitis suppurativa.
    Brunasso AM; Massone C
    Eur J Dermatol; 2010; 20(5):644-6. PubMed ID: 20615818
    [No Abstract]   [Full Text] [Related]  

  • 14. Pachyonychia congenita and hidradenitis suppurativa: no response to infliximab therapy.
    Pedraz J; Peñas PF; Garcia-Diez A
    J Eur Acad Dermatol Venereol; 2008 Dec; 22(12):1500-1. PubMed ID: 18482325
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term successful adalimumab therapy in severe hidradenitis suppurativa.
    Blanco R; Martínez-Taboada VM; Villa I; González-Vela MC; Fernández-Llaca H; Agudo M; González-López MA
    Arch Dermatol; 2009 May; 145(5):580-4. PubMed ID: 19451504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of recalcitrant hidradenitis suppurativa with ustekinumab.
    Sharon VR; Garcia MS; Bagheri S; Goodarzi H; Yang C; Ono Y; Maverakis E
    Acta Derm Venereol; 2012 May; 92(3):320-1. PubMed ID: 22101775
    [No Abstract]   [Full Text] [Related]  

  • 17. Hidradenitis suppurativa managed with adalimumab.
    Yamauchi PS; Mau N
    J Drugs Dermatol; 2009 Feb; 8(2):181-3. PubMed ID: 19213236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics?
    Ingram JR; Burton T
    Br J Dermatol; 2017 Feb; 176(2):281-282. PubMed ID: 28244073
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful long-term triple disease control by ustekinumab in a patient with Behcet's disease, psoriasis and hidradenitis suppurativa.
    Baerveldt EM; Kappen JH; Thio HB; van Laar JA; van Hagen PM; Prens EP
    Ann Rheum Dis; 2013 Apr; 72(4):626-7. PubMed ID: 23148307
    [No Abstract]   [Full Text] [Related]  

  • 20. New-onset polyarthritis during successful treatment of hidradenitis suppurativa with infliximab.
    van Rappard DC; Mooij JE; Baeten DL; Mekkes JR
    Br J Dermatol; 2011 Jul; 165(1):194-8. PubMed ID: 21428974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.